2026 MIPS Improvement Activity IA_PM_4: Glycemic management services
Written by Tucker Deyett, Dedicated Advisor, ReportingMD. Source data: CMS Quality Payment Program 2026 measure specifications and benchmark files.
Subcategory: Population Management
At a glance
IA_PM_4, Glycemic management services, is a 2026 MIPS improvement activity in the Population Management subcategory. For PY2026 activities are not weighted: clinicians with small practice, rural, non-patient-facing, or HPSA status attest to one activity, all other Traditional MIPS participants attest to two, and MVP participants attest to one.
Activity description
For outpatient Medicare beneficiaries with diabetes and who are prescribed antidiabetic agents (e.g., insulin, sulfonylureas), MIPS eligible clinicians and groups must attest to having: For the first performance year, at least 60 percent of medical records with documentation of an individualized glycemic treatment goal that: a) Takes into account patient-specific factors, including, at least 1) age, 2) comorbidities, and 3) risk for hypoglycemia, andb) Is reassessed at least annually.The performance threshold will increase to 75 percent for the second performance year and onward.Clinician would attest that, 60 percent for first year, or 75 percent for the second year, of their medical records that document individualized glycemic treatment represent patients who are being treated for at least 90 days during the performance period.
Activity details
- Activity ID: IA_PM_4
- Subcategory: Population Management
- Programs: Traditional MIPS, APP, APP Plus
- First performance year: 2017
Need help with IA_PM_4?
ReportingMD is a CMS qualified registry and healthcare data pipe with a 100% submission rate since 2001. We confirm IA attestations and documentation with every client before submission. Talk to a ReportingMD advisor or browse the full 2026 MIPS directory.